Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut 
Stellantis to End Plug-In Hybrid Sales in the U.S. as Demand Shifts Toward Traditional Hybrids 
FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling 
xAI Cash Burn Highlights the High Cost of Competing in Generative AI 
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside 
HSBC Expands UAE Presence With New Asset Management Business and Onshore Funds 
GM Takes $6 Billion EV Write-Down as Electric Vehicle Demand Slows in the U.S. 
Allegiant to Acquire Sun Country Airlines in $1.5 Billion Deal to Expand U.S. Leisure Travel Network 
AustralianSuper Backs BlueScope Steel’s Rejection of $9 Billion Takeover Bid 
Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks 
Trump Considers Starlink to Restore Internet Access in Iran Amid Protests 
Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue 
Nvidia Appoints Former Google Executive Alison Wagonfeld as First Chief Marketing Officer 
Hanwha Ocean Shares Rise on Plans to Expand U.S. Shipbuilding Capacity 
Supreme Court to Hear Cisco Appeal on Alien Tort Statute and Human Rights Liability 
FCC Approves Expansion of SpaceX Starlink Network With 7,500 New Satellites 
Johnson & Johnson Secures Tariff Exemption by Agreeing to Lower Drug Prices in the U.S. 
SCOTTSDALE, Ariz., Oct. 26, 2017 -- The Joint Corp. (NASDAQ:JYNT), a national operator, manager and franchisor of chiropractic clinics, announced it will issue its third quarter and year-to-date 2017 financial results on Thursday, November 9, 2017, after the market close. The company will hold a conference call at 5:00 p.m. ET that day to discuss the results.
Shareholders and interested participants may listen to a live broadcast of the conference call by dialing 765-507-2604 or 844-464-3931, and referencing participant code 8779909 approximately 10 minutes prior to the call. A live webcast of the conference call will be available on the investor relations section of the Company's website at ir.thejoint.com. An audio file of the call will also be archived for one week, and may be accessed by dialing 404-537-3406 or 855-859-2056 and entering conference ID 8779909.
About The Joint Corp. (NASDAQ:JYNT)
Based in Scottsdale, Arizona, The Joint is an emerging growth company that is reinventing chiropractic by making quality care convenient and affordable for patients seeking pain relief and ongoing wellness. Its no-appointment policy and convenient hours and locations make care more accessible, and affordable membership plans and packages eliminate the need for insurance. With nearly 400 clinics nationwide and more than four million patient visits annually, The Joint is a key leader in the chiropractic profession. For more information, visit www.thejoint.com or follow the brand on Twitter, Facebook, YouTube and LinkedIn.
Business Structure
The Joint Corp. is a franchisor of clinics and an operator of clinics in certain states. In Arkansas, California, Colorado, Florida, Illinois, Kansas, Minnesota, New Jersey, New York, North Carolina, Oregon, Pennsylvania, Tennessee and Washington, The Joint and its franchisees provide management services to affiliated professional chiropractic practices.
Investor Contact: Becky Herrick/Kirsten Chapman, LHA Investor Relations, 415-433-3777, [email protected]
Media Contact: Molly Hottle, The Joint Corp., [email protected]
